The value of AGR2 and KRT5 as an immunomarker combination in distinguishing lung squamous cell carcinoma from adenocarcinoma.

Pan, Bo; Wei, Zi-Xin; Zhang, Ju-Xuan; Li, Xin; Meng, Qing-Wei; Cao, Ying-Yue; Qi, Li-Shuang; Yu, Yan.

Affiliation

Pan B; Department of Medical Oncology, Harbin Medical University Cancer Hospital Harbin, China.
Wei ZX; Department of Medical Oncology, Harbin Medical University Cancer Hospital Harbin, China.
Zhang JX; College of Bioinformatics Science and Technology, Harbin Medical University Harbin, China.
Li X; College of Bioinformatics Science and Technology, Harbin Medical University Harbin, China.
Meng QW; Department of Medical Oncology, Harbin Medical University Cancer Hospital Harbin, China.
Cao YY; Department of Medical Oncology, Harbin Medical University Cancer Hospital Harbin, China.
Qi LS; College of Bioinformatics Science and Technology, Harbin Medical University Harbin, China.
Yu Y; Department of Medical Oncology, Harbin Medical University Cancer Hospital Harbin, China.

Am J Transl Res ; 13(5): 4464-4476, 2021.

Article in En | MEDLINE | ID: mdl-34150027